The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
11 reports and counting
Novartis Raises $220B in Public
Novartis, a Pharmaceuticals company based in Lichtstrasse 35, Basel 4056, Switzerland, has raised $220B in Public at a $240B valuation led by Public.
Novartis raises $220B Public at $240B valuation
Novartis raises $220B in Public at $240B valuation. Pharmaceutical company...
Novartis Headquarters - Office Location & Address
Discover Novartis's headquarters at Lichtstrasse 35, Basel 4056. Pharmaceutical company. Learn about the office facilities and work environment.
Novartis Venture Fund Headquarters - Office Location & Address
Discover Novartis Venture Fund's headquarters at 22 Windsor St, Cambridge, MA 02139. Corporate venture capital from Novartis investing in life sciences and healthcare innovation globally. Portfolio includes biotechnology, digital health, diagnostics, and precision medicine companies.
Novartis US Headquarters - Office Location & Address
Discover Novartis US's headquarters at 1 Health Plaza, East Hanover, NJ 07936. Pharmaceutical company. Learn about the office facilities and work environment.
Intellia Therapeutics Raises $350M in Follow-on Offering
Intellia Therapeutics, a Biotech company based in 40 Erie Street, Cambridge, MA 02139, has raised $350M in Follow-on Offering at a $4.5B valuation led by Atlas Venture, Novartis Venture Fund, Venrock, Lilly Asia Ventures.
Vor Biopharma Raises $110M in Series C
Vor Biopharma, a Biotech company based in 200 Sidney Street, Cambridge, MA 02139, has raised $110M in Series C at a $700M valuation led by 5AM Ventures, Fidelity, SR One, Novartis Venture Fund, Cormorant Asset Management.
Intellia Therapeutics raises $350M Follow-on Offering at $4.5B valuation
Intellia Therapeutics raises $350M in Follow-on Offering at $4.5B valuation. In vivo CRISPR gene editing...
Vor Biopharma raises $110M Series C at $700M valuation
Vor Biopharma raises $110M in Series C at $700M valuation. Engineering hematopoietic stem cells...
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.